Toll-like receptor 4 is involved in the cell cycle modulation and required for effective human cytomegalovirus infection in THP-1 macrophages (Q39180559)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 13 March 2013

Language	Label	Description	Also known as
English	Toll-like receptor 4 is involved in the cell cycle modulation and required for effective human cytomegalovirus infection in THP-1 macrophages	scientific article published on 13 March 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Toll-like receptor 4 is involved in the cell cycle modulation and required for effective human cytomegalovirus infection in THP-1 macrophages (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Cytomegalovirus

0 references

toll-like receptor

0 references

cytomegaloviral disease

1 reference

based on heuristic

inferred from title

5

0 references

Prisco Mirandola

0 references

object named as

Diego Germini

2

0 references

author name string

Maria-Cristina Arcangeletti

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Isabella Rodighiero

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Maria-Cristina Medici

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Rita Gatti

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Carlo Chezzi

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Adriana Calderaro

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

language of work or name

0 references

publication date

13 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

440

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

19-30

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Human cytomegalovirus proteins PP65 and IEP72 are targeted to distinct compartments in nuclei and nuclear matrices of infected human embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Cell-cycle-dependent localization of human cytomegalovirus UL83 phosphoprotein in the nucleolus and modulation of viral gene expression in human embryo fibroblasts in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

The S phase of the cell cycle and its perturbation by human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Human cytomegalovirus protects endothelial cells from apoptosis induced by growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Innate sensing of viruses by toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Association of Cytomegalovirus Infection and Disease With Death and Graft Loss After Liver Transplant in High-Risk Recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Viral Subversion Mechanisms in Chronic Kidney Disease Pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Herpesviral infection and Toll-like receptor 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

HCMV infection: modulating the cell cycle and cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

The Influence of Innate Immunity Gene Receptors Polymorphisms in Renal Transplant Infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Phospholipase Cγ-2 and intracellular calcium are required for lipopolysaccharide-induced Toll-like receptor 4 (TLR4) endocytosis and interferon regulatory factor 3 (IRF3) activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Relevance of Toll-like receptor-4 polymorphisms in renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Translational control of viral gene expression in eukaryotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Influenza virus and cell signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Hydrogen sulfide impairs keratinocyte cell growth and adhesion inhibiting mitogen-activated protein kinase signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Differential inhibition of human cytomegalovirus (HCMV) by toll-like receptor ligands mediated by interferon-beta in human foreskin fibroblasts and cervical tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Toll-like receptor signaling stimulates cell cycle entry and progression in fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of Pseudomitosis independent of US28 function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Cyclin E in normal and neoplastic cell cycles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Control of human cytomegalovirus gene expression by differential histone modifications during lytic and latent infection of a monocytic cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

A proviral role for CpG in cytomegalovirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Hantaan virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon, interleukin-6 and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Production of proinflammatory cytokines by syncytiotrophoblasts infected with human cytomegalovirus isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Toll-like receptor 4 Asp299Gly polymorphism in respiratory syncytial virus epidemics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Induction of endothelial cell damage by hCMV molecular mimicry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Down-regulation of human leukocyte antigen class I and II and beta 2-microglobulin expression in human herpesvirus-7-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Virus self-improvement through inflammation: no pain, no gain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Legionella pneumophila induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Cyclin A is required at two points in the human cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Cross-talk among Toll-like receptors and their ligands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Outcome of confirmed symptomatic congenital cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Human cytomegalovirus mediates cell cycle progression through G(1) into early S phase in terminally differentiated cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Latency and reactivation of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Inhibition of cell division by the human cytomegalovirus IE86 protein: role of the p53 pathway or cyclin-dependent kinase 1/cyclin B1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Cytomegalovirus-induced immunopathology and its clinical consequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Human cytomegalovirus immediate-early protein 2 (IE2)-mediated activation of cyclin E is cell-cycle-independent and forces S-phase entry in IE2-arrested cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

The immunoregulatory effects of CMV-infection in human fibroblasts and the impact on cellular senescence.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Toll-Like Receptors and Viruses: Induction of Innate Antiviral Immune Responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

TLRs antiviral effect on hepatitis B virus in HepG2 cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

CD14 controls the LPS-induced endocytosis of Toll-like receptor 4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.021

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2013.01.021

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39180559&oldid=1811921182"